1-4 of 4
Gerard J. te Meerman
Close
Sort by
Journal Articles

HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV + Hodgkin lymphoma

Marijke Niens, Ruth F. Jarrett, Bouke Hepkema, Ilja M. Nolte, Arjan Diepstra, Mathieu Platteel, Niels Kouprie, Craig P. Delury, Alice Gallagher, Lydia Visser, Sibrand Poppema, Gerard J. te Meerman, Anke van den Berg
Journal: Blood
Blood (2007) 110 (9): 3310–3315.
https://doi.org/10.1182/blood-2007-05-086934
Published: 2007
Journal Articles

TARC and MDC Are the Only Chemokines with Highly Increased Levels in Serum of Hodgkin Lymphoma Patients.

Marijke Niens, MSc, Lydia Visser, PhD, Ruth F. Jarrett, MD, Gerard J. te Meerman, PhD, Sibrand Poppema, MD, Anke van den Berg, PhD
Journal: Blood
Blood (2006) 108 (11): 2268.
https://doi.org/10.1182/blood.V108.11.2268.2268
Published: 2006
Journal Articles

Haplotype-Based Sequencing To Delineate the Associated HLA Class I Region for EBV Positive Hodgkin Lymphoma.

Marijke Niens, MSc, Anke van den Berg, PhD, Arjan Diepstra, MD, Ilja M. Nolte, PhD, Gerrit van der Steege, PhD, Ruth F. Jarrett, MD, Siebrand Poppema, MD, Gerard J. te Meerman, PhD
Journal: Blood
Blood (2005) 106 (11): 971.
https://doi.org/10.1182/blood.V106.11.971.971
Published: 2005
Journal Articles

Population Based Genotyping of Human Leukocyte Antigen (HLA) in Hodgkin Lymphoma: EBV Positive HL Is Associated with HLA Class I and EBV Negative HL Is Associated with HLA Class III.

Arjan Diepstra, MD, Marijke Niens, MSc, Edo Vellenga, MD, PhD, Gerard J. te Meerman, PhD, Michael Schaapveld, PhD, Ilja M. Nolte, PhD, Gustaaf W. van Imhoff, MD, Sibrand Poppema, MD, PhD
Journal: Blood
Blood (2004) 104 (11): 432.
https://doi.org/10.1182/blood.V104.11.432.432
Published: 2004